Dactinomycin and Heparin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dactinomycin (dactinomycin) and Heparin (heparin sodium). Common drug interactions include drug toxicity among females and compartment syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Dactinomycin and Heparin. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Dactinomycin?

Dactinomycin has active ingredients of dactinomycin. eHealthMe is studying from 2,577 Dactinomycin users. Check the latest studies of Dactinomycin.

What is Heparin?

Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.



On Jul, 29, 2026

47 people who take Dactinomycin and Heparin together, and have interactions are studied.

Dactinomycin and Heparin drug interactions.

What are the common drug interactions of Dactinomycin and Heparin, by gender? *:

female:

  1. Drug toxicity
  2. Device failure
  3. Headache (pain in head)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Pleural effusion (water on the lungs)
  6. Pyrexia (fever)
  7. Respiratory disorder (respiratory disease)
  8. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  9. Abdominal pain
  10. Ascites (accumulation of fluid in the abdominal cavity)

male:

  1. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  2. Death
  3. Drug toxicity
  4. Hospitalisation
  5. Pyrexia (fever)
  6. Vomiting

What are the common drug interactions of Dactinomycin and Heparin, by age (0-1 to 60+)? *:

0-1:

  1. Ascites (accumulation of fluid in the abdominal cavity)
  2. Coagulopathy (blood's ability to clot is impaired)
  3. Death
  4. Hospitalisation
  5. Hyperbilirubinaemia (excess of bilirubin in the blood)
  6. Pleural effusion (water on the lungs)
  7. Pyrexia (fever)
  8. Respiratory disorder (respiratory disease)
  9. Transaminases increased
  10. Venoocclusive disease (small veins in the liver are obstructed)

2-9:

  1. Pleural effusion (water on the lungs)
  2. Respiratory disorder (respiratory disease)
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
  5. Coagulopathy (blood's ability to clot is impaired)
  6. Hyperbilirubinaemia (excess of bilirubin in the blood)
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Pulmonary hypertension (increase in blood pressure in the lung artery)
  9. Transaminases increased
  10. Venoocclusive disease (small veins in the liver are obstructed)

10-19:

  1. Abdominal pain
  2. Fatigue (feeling of tiredness)
  3. Headache (pain in head)
  4. Hypotension (abnormally low blood pressure)
  5. Myalgia (muscle pain)
  6. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  7. Pyrexia (fever)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Gait disturbance
  10. Motor neurone disease (a rare condition where parts of the nervous system become damaged, causing progressive weakness)

20-29:

  1. Device failure
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  5. Hypotension (abnormally low blood pressure)
  6. Hypoxia (low oxygen in tissues)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Bone marrow failure

30-39:

  1. Ototoxicity (damage to the ear)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Tinnitus (a ringing in the ears)

40-49:

n/a

50-59:

  1. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  2. Drug toxicity

60+:

  1. Cellulitis (infection under the skin)
  2. Drug toxicity
  3. Medical device complication
  4. Systemic leakage (a condition in which fluid and proteins leak out of tiny blood vessels and flow into surrounding tissues)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  7. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  8. Urinary tract infection
  9. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  10. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)

What are the existing conditions these people have? *

  1. Malignant Melanoma Stage Iii (cancer has spread to one or more lymph nodes): 12 people, 25.53%
  2. Skin Cancer: 6 people, 12.77%
  3. Malignant Soft Tissue Neoplasm (cancer tumour of soft tissue): 4 people, 8.51%
  4. Gestational Trophoblastic Tumor: 4 people, 8.51%
  5. Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 3 people, 6.38%
  6. Malignant Melanoma (skin cancer rises from melancytes): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Dactinomycin and Heparin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dactinomycin and Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dactinomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dactinomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Heparin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dactinomycin and heparin sodium (the active ingredients of Dactinomycin and Heparin, respectively), and Dactinomycin and Heparin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: